Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is effective for tracking treatment progress in hair loss when used by an experienced doctor.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Copper treatments increase copper in all tissues, but brindled female mice accumulate much more copper in their kidneys without clinical effects, unlike brindled male mice where brain copper deficiency is clinically significant.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Patients with systemic lupus erythematosus and hair loss had non-scarring alopecia with fewer hair follicles, and direct immunofluorescence did not help identify lupus.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

There might be a specific histone code for cellular quiescence, but more research is needed.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.